ARCHIVES

Group chairmen Advises 7 Trials For Priority Status

This article is from The Cancer Letter archive.

Vol. 17 No. 24 | June 14, 1991

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: Survivorship Programs Win Funds To form Model Programs

December 13, 1996

NCI CTEP Approved Trials For the Month of January

January 31, 2014

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

May 27, 2011

DCE Recompetition Of Human Tissue Procurement Approved

November 23, 1990

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

August 16, 1991

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003